Andrea Bezzeccheri, Enrico Poletti, Paul Vermeersch, Verena Veulemans, Jarkko Piuhola, Seija Kerkelä, Heidi Lehtola, Ole De Backer, Angelo Quagliana, Concetta Mammone, Flavio Ribichini, Edgard Prihadi, Benjamin Scott, Carlo Zivelonghi, Stefan Verheye, Pierfrancesco Agostoni
Transcatheter aortic valve implantation (TAVI) is an established treatment strategy in aortic valve disease. Infolding, as a non-uniform expansion of the prosthesis leading to introflection of part of the device circumference, is a complication specific to self-expandable prostheses. The aim of the study is to determine incidence, predictors, treatment strategy and outcomes of infolding during Medtronic™ Evolut TAVI. Between January 2018 and March 2022 all patients treated with Evolut TAVI were included in a multicenter observational retrospective study...
April 16, 2024: American Journal of Cardiology